Infectious Diseases (except HIV/AIDS)
Showing page 274 of 716 pages of list content
-
The Persistence of Neutralising Antibodies up to 11 months after SARS-CoV-2 Infection in the Southern Region of New Zealand
This article's authors -
In vitro characterisation and clinical evaluation of the diagnostic accuracy of a new antigen test for SARS-CoV-2 detection
This article's authors -
Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections
This article's authors -
Safety Monitoring of mRNA Vaccines Administered During the Initial 6 Months of the U.S. COVID-19 Vaccination Program: Reports to Vaccine Adverse Events Reporting System (VAERS) and v-safe
This article's authors -
Dampening of the respiratory cytokine storm is promoted by inhaled budesonide in patients with early COVID-19
This article's authors -
Transmission dynamics of SARS-CoV-2 in a strictly-Orthodox Jewish community in the UK
This article's authors -
Time of day of vaccination affects SARS-CoV-2 antibody responses in an observational study of healthcare workers
This article's authors -
Two-dose SARS-CoV-2 vaccine effectiveness with mixed schedules and extended dosing intervals: test-negative design studies from British Columbia and Quebec, Canada
This article's authors -
Limited impact of Delta variant’s mutations in the effectiveness of neutralization conferred by natural infection or COVID-19 vaccines in a Latino population
This article's authors -
A scalable serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccination
This article's authors